Word

Status

Pending

Status Code

686

Status Date

Tuesday, August 6, 2024

Serial Number

98126260

Mark Type

2

Filing Date

Thursday, August 10, 2023

Published for Opposition

Tuesday, August 6, 2024

Trademark Owner History

Glaxo Group Limited - Owner At Publication

Classifications

5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of bacterial diseases and infections

The mark consists of a stylized bow and arrow.
Color is not claimed as a feature of the mark.

Trademark Events

Aug 14, 2023

New Application Entered

Sep 10, 2023

New Application Office Supplied Data Entered

Sep 12, 2023

Notice Of Design Search Code E-Mailed

Mar 25, 2024

Assigned To Examiner

Apr 1, 2024

Letter Of Suspension E-Mailed

Apr 1, 2024

Notification Of Letter Of Suspension E-Mailed

Jun 18, 2024

Teas Response To Suspension Inquiry Received

Jun 20, 2024

Correspondence Received In Law Office

Jun 20, 2024

Teas/Email Correspondence Entered

Nov 9, 2023

Teas Voluntary Amendment Received

Apr 1, 2024

Suspension Letter Written

Apr 1, 2024

Assigned To Lie

Jul 1, 2024

Approved For Pub - Principal Register

Jul 17, 2024

Notification Of Notice Of Publication E-Mailed

Aug 6, 2024

Published For Opposition

Aug 6, 2024

Official Gazette Publication Confirmation E-Mailed